*Department of Microbiology and Infectious Diseases, Royal Prince Alfred Hospital, Sydney, Australia;
†School of Management and Engineering Vaud (HEIG-VD), University of Applied Science Western Switzerland (HES-SO), Yverdon-les-Bains, Switzerland;
‡Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia; and
§University of Sydney Central Clinical School, University of Sydney, Australia.
Correspondence: Philip G. Drennan, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom, OX3 9DU (e-mail: [email protected]).
P. G. Drennan conceived the study, assisted with data collection, analyzed the data, and drafted the manuscript. L. Barry collected the data and reviewed the manuscript. Y. Thoma and J. Matthey performed the simulations and reviewed the manuscript. S. Sivam supported the development of the TDM service and data collection and reviewed the manuscript. S. van Hal conceived the study and reviewed the manuscript.
The authors declare no conflict of interest.
Data requests should be submitted to the corresponding author. Access to deidentified data stored in the synapse.org repository may be granted to suitably qualified researchers after review.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.drug-monitoring.com).
